1. Genetic regulation of longevity and age-associated diseases through the methionine sulfoxide reductase system
   Derek B. Oien et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
2. The potential applications of traditional Chinese medicine in Parkinson's disease: A new opportunity
   Jiaxue Chen et al, 2022, Biomedicine & Pharmacotherapy CrossRef
3. Astragaloside IV Protects Ethanol-Induced Gastric Mucosal Injury by Preventing Mitochondrial Oxidative Stress and the Activation of Mitochondrial Pathway Apoptosis in Rats
   Shumin Qin et al, 2019, Frontiers in Pharmacology CrossRef
4. Roles and Mechanisms of Astragaloside IV in Combating Neuronal Aging
   Qumar Zaman et al, 2022, Aging and disease CrossRef
5. The importance of choosing a preclinical model that reflects what happens in Parkinson's disease
   Juan Segura-Aguilar, 2019, Neurochemistry International CrossRef
6. Amelioration of Mitochondrial Quality Control and Proteostasis by Natural Compounds in Parkinson’s Disease Models
   Bongki Cho et al, 2019, International Journal of Molecular Sciences CrossRef
7. The pathogenesis and treatment mechanism of Parkinson's disease from the perspective of traditional Chinese medicine
   Peng Chen et al, 2022, Phytomedicine CrossRef
8. Research Progress on Natural Product Ingredients’ Therapeutic Effects on Parkinson’s Disease by Regulating Autophagy
   Sicong Li et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
9. Research progress of the effective active ingredients of Astragalus mongholicus in the treatment of diabetic peripheral neuropathy
   Yulian Liu et al, 2024, Biomedicine & Pharmacotherapy CrossRef
10. Recombinant Humanized IgG1 Antibody Protects against oxLDL-Induced Oxidative Stress and Apoptosis in Human Monocyte/Macrophage THP-1 Cells by Upregulation of MSRA via Sirt1-FOXO1 Axis
    Qi Zhang et al, 2022, International Journal of Molecular Sciences CrossRef